Ortin Global Limited - Asset Resilience Ratio

Latest as of September 2024: 2.07%

Ortin Global Limited (ORTINGLOBE) has an Asset Resilience Ratio of 2.07% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Ortin Global Limited (ORTINGLOBE) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs833.00K
≈ $9.01K USD Cash + Short-term Investments

Total Assets

Rs40.31 Million
≈ $435.94K USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Ortin Global Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see ORTINGLOBE asset base.

Liquid Assets Composition Over Time

This chart breaks down Ortin Global Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read ORTINGLOBE total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs833.00K 2.07%
Total Liquid Assets Rs833.00K 2.07%

Asset Resilience Insights

  • Limited Liquidity: Ortin Global Limited maintains only 2.07% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Ortin Global Limited Industry Peers by Asset Resilience Ratio

Compare Ortin Global Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Yunnan Baiyao Group Co Ltd
SHE:000538
Drug Manufacturers - Specialty & Generic 8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
Drug Manufacturers - Specialty & Generic 6.62%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Harbin Gloria Pharmaceuticals
SHE:002437
Drug Manufacturers - Specialty & Generic 9.04%
Jiuzhitang Co Ltd
SHE:000989
Drug Manufacturers - Specialty & Generic 7.86%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%

Annual Asset Resilience Ratio for Ortin Global Limited (2021–2024)

The table below shows the annual Asset Resilience Ratio data for Ortin Global Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-03-31 28.26% Rs18.83 Million
≈ $203.67K
Rs66.64 Million
≈ $720.72K
+28.09pp
2023-03-31 0.17% Rs361.00K
≈ $3.90K
Rs211.97 Million
≈ $2.29 Million
-0.33pp
2022-03-31 0.50% Rs1.03 Million
≈ $11.16K
Rs207.05 Million
≈ $2.24 Million
-0.21pp
2021-03-31 0.71% Rs1.51 Million
≈ $16.32K
Rs212.66 Million
≈ $2.30 Million
--
pp = percentage points

About Ortin Global Limited

NSE:ORTINGLOBE India Drug Manufacturers - Specialty & Generic
Market Cap
$1.39 Million
Rs128.72 Million INR
Market Cap Rank
#30456 Global
#1681 in India
Share Price
Rs15.83
Change (1 day)
-3.77%
52-Week Range
Rs11.19 - Rs19.92
All Time High
Rs19.92
About

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quin… Read more